Chief Scientific Officer · Immunome Inc. · Immunome Inc. — Employee Stock Option (right to buy)
Side
M
Value
—
Shares
18.0K
Price
—
Executed
Sep 11, 2026
Disclosed
Sep 15, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Sep 11 executedSep 15, 2026 disclosed
IMNM · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 15.5% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Immunome Inc. — Employee Stock Option (right to buy)
Ticker
IMNM
Shares
18.0K
Price per share
$0
Execution date (reported)
Sep 11, 2026
Owned after transaction
133.8K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
4
What this establishes
Higgins Jack filed this Form 4 reporting a option exercise of IMNM on Sep 11, 2026. It became public on Sep 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Higgins Jackcik:0001993684
Issuer
Immunome Inc.cik:0001472012
Revision history · 0
No field has changed since this record was first ingested.
